Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation

被引：30
|
作者：
Soni, Sandeep [1 ]
Skeens, Micah [1 ]
Termuhlen, Amanda M. [1 ]
Bajwa, Rajinder P. S. [1 ]
Gross, Thomas G. [1 ]
Pai, Vinita [1 ,2 ]
机构：
[1] Nationwide Childrens Hosp, Div Pediat Hematol Oncol & BMT, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 04期
关键词：
BMT; busulfan; levetiracetam; seizures; HIGH-DOSE BUSULFAN; ACUTE-LEUKEMIA PATIENTS; MARROW TRANSPLANTATION; DRUG-INTERACTIONS; PHARMACOKINETICS; CYCLOPHOSPHAMIDE; LORAZEPAM;
D O I：
10.1002/pbc.24126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anti-seizure prophylaxis is routinely utilized during busulfan administration for HSCT. We evaluated the feasibility and efficacy of levetiracetam in children undergoing HSCT. A total of 28 children and young adults received levetiracetam during HSCT and the outcomes and costs were compared to a historical, but similar cohort of 25 patients who had received fosphenytoin. Levetiracetam was well tolerated and was efficacious in preventing seizures. Cost of drug, administration, and monitoring were also similar among the two groups. Due to non-induction of the hepatic cytochrome P450 enzymes, levetiracetam may lead to better dose assurance of busulfan in targeted dose regimens for HSCT. Pediatr Blood Cancer 2012;59:762764. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码：762 / 764
页数：3
相关论文
共 50 条
  • [31] Transplantation in children - Energy expenditure in children undergoing hematopoietic stem cell transplantation
    Ringwald-Smith, KA
    Heslop, HE
    Krance, RA
    Mackert, PW
    Hancock, ML
    Stricklin, LM
    Bowman, LC
    Hale, GA
    BONE MARROW TRANSPLANTATION, 2002, 30 (02) : 125 - 130
  • [32] A comparison between busulfan pharmacokinetics in children with thalassernia major and neuroblastoma undergoing hematopoietic stem cell transplantation (HSCT)
    Hoffer, Erica
    Elhasid, Ronit
    Bentur, Yedidia
    Stein, Jerry
    Krivoy, Norberto
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 537 - 537
  • [33] Population pharmacokinetics of busulfan in Saudi pediatric patients undergoing hematopoietic stem cell transplantation
    Alsultan, Abdullah
    Albassam, Ahmed A.
    Alturki, Abdullah
    Alsultan, Abdulrahman
    Essa, Mohammed
    Almuzzaini, Bader
    Alfadhel, Salman
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (02) : 703 - 712
  • [34] Population pharmacokinetic of oral busulfan in Japanese undergoing hematopoietic stem cell transplantation.
    Sasaki, N
    Ogata, K
    Yamauchi, K
    Takamatsu, Y
    Suzumiya, J
    Tamura, K
    Yukawa, E
    Hara, S
    Ono, N
    BLOOD, 2005, 106 (11) : 414B - 414B
  • [35] Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation
    JS McCune
    T Gooley
    JP Gibbs
    JE Sanders
    EW Petersdorf
    FR Appelbaum
    C Anasetti
    L Risler
    D Sultan
    JT Slattery
    Bone Marrow Transplantation, 2002, 30 : 167 - 173
  • [36] Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation
    McCune, JS
    Gooley, T
    Gibbs, JP
    Sanders, JE
    Petersdorf, EW
    Appelbaum, FR
    Anasetti, C
    Risler, L
    Sultan, D
    Slattery, JT
    BONE MARROW TRANSPLANTATION, 2002, 30 (03) : 167 - 173
  • [37] Busulfan Pharmacogenetics and Drug Exposure in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation
    Patel, Jai N.
    Hamadeh, Issam
    Zhang, Qing
    Brown, Taylor
    Steuerwald, Nury M.
    Hamilton, Alicia
    Druhan, Lawrence J.
    He, Jiaxian
    Symanowski, James T.
    Hussain, Mohammed J.
    Trivedi, Jigar
    Grunwald, Michael Richard
    Ghosh, Nilanjan
    Avalos, Belinda Rene
    Copelan, Edward A.
    BLOOD, 2017, 130
  • [38] Population pharmacokinetics of busulfan in Saudi pediatric patients undergoing hematopoietic stem cell transplantation
    Abdullah Alsultan
    Ahmed A. Albassam
    Abdullah Alturki
    Abdulrahman Alsultan
    Mohammed Essa
    Bader Almuzzaini
    Salman Alfadhel
    International Journal of Clinical Pharmacy, 2020, 42 : 703 - 712
  • [39] Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation
    Pfeiffer, Thomas
    Lockowitz, Christine R.
    Shenoy, Shalini
    Mavers, Melissa
    Hayashi, Robert
    Bednarski, Jeffrey
    Green, Abby
    BONE MARROW TRANSPLANTATION, 2024, 59 (08) : 1193 - 1195
  • [40] Efficacy and toxicity of intravenous busulfan before hematopoietic stem cell transplantation in children
    Styczynski, Jan
    Debski, Robert
    Krenska, Anna
    Wysocki, Mariusz
    BONE MARROW TRANSPLANTATION, 2008, 42 : S126 - S126
12345